KSHV induction of angiogenic and lymphangiogenic phenotypes

Frontiers in Microbiology

Volumn 3, Issue MAR, 2012, Pages

  DiMaio, Terri A ^a   Lagunoff, Michael ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Angiogenesis; HHV 8; Kaposi's sarcoma; Kaposi's Sarcoma associated herpesvirus; Lymphangiogenesis; Viral oncogenesis

Indexed keywords

EID: 84875673722     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00102     Document Type: Article

References (87)

1. Akula, S. M., Ford, P. W., Whitman, A. G., Hamden, K. E., Bryan, B. A., Cook, P. P., and McCubrey, J. A. (2005). B-Raf-dependent expression of vascular endothelial growth factor-A in Kaposi sarcoma-associated herpesvirus-infected human B cells. Blood 105, 4516-4522.
2. Aoki, Y., Jaffe, E. S., Chang, Y., Jones, K., Teruya-Feldstein, J., Moore, P. S., and Tosato, G. (1999). Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93, 4034-4043.
3. Arvanitakis, L., Geras-Raaka, E., Varma, A., Gershengorn, M. C., and Cesar-man, E. (1997). Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385, 347-350.
4. Bais, C., Santomasso, B., Coso, O., Arvanitakis, L., Raaka, E. G., Gutkind, J. S., Asch, A. S., Cesarman, E., Gershengorn, M. C., Mesri, E. A., and Gerhengorn, M. C. (1998). G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391, 86-89.
5. Bais, C., Van Geelen, A., Eroles, P., Mutlu, A., Chiozzini, C., Dias, S., Silverstein, R. L., Rafii, S., and Mesri, E. A. (2003). Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Cancer Cell 3, 131-143.
6. Beral, V., Peterman, T. A., Berkelman, R. L., and Jaffe, H. W. (1990). Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335, 123-128.
7. Blasig, C., Zietz, C., Haar, B., Neipel, E, Esser, S., Brockmeyer, N. H., Tschachler, E., Colombini, S., Ensoli, B., and Stürzl, M. (1997). Mono-cytes in Kaposi's sarcoma lesions are pro ductively infected by human herpesvirus 8. J. Virol. 71, 7963-7968.
8. Boshoff, C., Endo, Y., Collins, P. D., Takeuchi, Y., Reeves, J. D., Schweickart, V L., Siani, M. A., Sasaki, T., Williams, T. J., Gray, P. W., Moore, P. S., Chang, Y., and Weiss, R. A. (1997). Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278, 290-294.
9. Boshoff, C., Schulz, T. F., Kennedy, M. M., Graham, A. K., Fisher, C., Thomas, A., McGee, J. O., Weiss, R. A., and O'Leary, J. J. (1995). Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat. Med. 1,1274-1278.
10. Breen, E. C. (2007). VEGF in biological control. J. Cell. Biochem. 102, 1358-1367.
11. Brown, L. F., Dezube, B. J., Tognazzi, K., Dvorak, H. F., and Yancopoulos, G. D. (2000). Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am. J. Pathol. 156, 2179-2183.
12. Cai, Q., Murakami, M., Si, H., and Robertson, E. S. (2007). A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alphainnormoxia. J. Virol. 81, 10413-10423.
13. Cai, Q. L., Knight, J. S., Verma, S. C., Zald, P., and Robertson, E. S. (2006). EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. PLoS Pathog. 2, e1 16. doi:10.1371/jour-nal.ppat.0020116
14. Cai, X., Lu, S., Zhang, Z., Gonzalez, C. M., Damania, B., and Cullen, B. R. (2005). Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc. Natl.Acad. Sci. U.S.A. 102, 5570-5575.
15. Cao, Y. (2009). Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci. Signal. 2,re1.
16. Carroll, P. A., Brazeau, E., and Lagunoff, M. (2004). Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. Virology 328,7-18.
17. Carroll, P. A., Kenerson, H. L., Yeung, R. S., and Lagunoff, M. (2006). Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors. J. Virol. 80, 10802-10812.
18. Caselli, E., Fiorentini, S., Amici, C., Di Luca, D., Caruso, A., and Santoro, M. G. (2007). Human herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattrac-tant protein 1-dependent capillary-like structure formation: role of the IKK/NF-kappaB pathway. Blood 109,2718-2726.
19. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W., and Knowles, D. M. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl. J. Med. 332, 1186-1191.
20. Chandriani, S., and Ganem, D. (2010). Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 84, 5565-5573.
21. Chandriani, S., Xu, Y., and Ganem, D. (2010). The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes. J. Virol. 84, 7934-7942.
22. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., and Moore, P. S. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869.
23. Chatterjee, M., Osborne, J., Bestetti, G., Chang, Y., and Moore, P. S. (2002). Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298, 1432-1435.
24. Couty, J. P., Lupu-Meiri, M., Oron, Y., and Gershengorn, M. C. (2009). Kaposi's sarcoma-associated herpesvirus-G protein-coupled receptor-expressing endothelial cells exhibit reduced migration and stimulated chemotaxis by chemokine inverse agonists. J. Pharmacol Exp. Ther. 329, 1142-1147.
25. Dai, L., Bratoeva, M., Toole, B. P., Qin, Z., and Parsons, C. (2011). KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upreg-ulation of emmprin-induced signal transduction. Int. J. Cancer. doi:10.1002/ijc.26428
26. DiMaio, T. A., Gutierrez, K. D., and Lagunoff, M. (2011). Latent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypes. PLoS Pathog. 7, e1002424. doi:10.1371/journal.ppat.1002424
27. Dumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A., and Breitman, M. L. (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculoge-nesis of the embryo. Genes Dev. 8, 1897-1909.
28. Dupin, N., Fisher, C., Kellam, P., Ariad, S., Tulliez, M., Franck, N., van Marck, E., Salmon, D., Gorin, I., Escande, J. P., Weiss, R. A., Alitalo, K.,andBoshoff,C. (1999). Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. U.S.A. 96, 4546-4551.
29. Dwyer, J., Le Guelte, A., Galan Moya, E. M., Sumbal, M., Carlotti, A., Douguet, L., Gutkind, J. S., Grange,P. A., Dupin, N., and Gavard, J. (2011). Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor. Oncogene 30,190-200.
30. Fong, G. H., Rossant, J., Gertsenstein, M., and Breitman, M. L. (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70.
31. Fonsato, V., Buttiglieri, S., Deregibus, M. C., Bussolati, B., Caselli, E., Di Luca, D., and Camussi, G. (2008). PAX2 expression by HHV-8-infected endothelial cells induced a proan-giogenic and proinvasive phenotype. Blood 111,2806-2815.
32. Gale, N. W., Thurston, G., Hackett, S. E, Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, D., Suri, C., Campochiaro, P. A., Wiegand, S. J., and Yancopou-los, G. D. (2002). Angiopoietin-2 is required for postnatal angiogen-esis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev. Cell 3,411-423.
33. Gialeli, C., Theocharis, A. D., and Kara-manos, N. K. (2011). Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 278, 16-27.
34. Guilluy, C., Zhang, Z., Bhende, P. M., Sharek, L., Wang, L., Burridge, K., and Damania, B. (2011). Latent KSHV infection increases the vascular permeability of human endothelial cells. Blood 118, 5344-5354.
35. Guo, H. G., Sadowska, M., Reid, W., Tschachler, E., Hayward, G., and Reitz, M. (2003). Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J. Virol. 77,2631-2639.
36. Hansen, A., Henderson, S., Lagos, D., Nikitenko, L., Coulter, E., Roberts, S., Gratrix, F., Plaisance, K., Renne, R., Bower, M., Kellam, P., and Boshoff, C. (2010). KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Genes Dev. 24, 195-205.
37. Hong, Y K., Foreman, K., Shin, J. W., Hirakawa, S., Curry, C. L., Sage, D. R., Libermann, T., Dezube, B. J., Fingeroth, J. D., and Detmar, M. (2004). Lymphatic reprogram ming of blood vascular endothelium by Kaposi sarcoma-associated her pesvirus. Nat. Genet. 36, 683-685.
38. Jussila, L., Valtola, R., Partanen, T. A., Salven, P., Heikkilä, P., Matikainen, M. T., Renkonen, R., Kaipainen, A., Detmar, M., Tschachler, E., Alitalo, R., and Alitalo, K. (1998). Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 58, 1599-1604.
39. Liu, C., Okruzhnov, Y., Li, H., and Nicholas, J. (2001). Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects. J. Virol. 75, 10933-10940.
40. Ma, T., Jham, B. C., Hu, J., Friedman, E. R., Basile, J. R., Moli-nolo, A., Sodhi, A., and Montaner, S. (2010). Viral G protein-coupled receptor up-regulates angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma. Proc. Natl. Acad. Sci. U.S.A. 107,14363-14368.
41. Mansouri, M., Douglas, J., Rose, P. P., Gouveia, K., Thomas, G., Means, R. E., Moses, A. V., and Früh, K. (2006). Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells. Blood 108, 1932-1940.
42. Mansouri, M., Rose, P. P., Moses, A. V., and Früh, K. (2008). Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus. J. Virol. 82, 9615-9628.
43. Marshall, V., Parks, T., Bagni, R., Wang, C. D., Samols, M. A., Hu, J., Wyvil, K. M., Aleman, K., Little, R. F., Yarchoan, R., Renne, R., and Whitby, D. (2007). Conservation of virally encoded microRNAs in Kaposi sar coma - associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. J. Infect. Dis. 195, 645-659.
44. Masood, R., Cesarman, E., Smith, D. L., Gill, P. S., and Flore, O. (2002). Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. Am. J. Pathol. 160, 23-29.
45. Montaner, S., Sodhi, A., Pece, S., Mesri, E. A., and Gutkind, J. S. (2001). The Kaposi's sarcoma-associated her pesvirus G protein-coupled recep tor promotes endothelial cell sur vival through the activation of Akt/protein kinase B. Cancer Res. 61, 2641-2648.
46. Morris, V A., Punjabi, A. S., and Lagunoff, M. (2008). Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells. J. Virol. 82, 8771-8779.
47. Morris, V A., Punjabi, A. S., Wells, R. C., Wittkopp, C. J., Vart, R., and Lagunoff, M. (2012). The KSHV Viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation. Virology. (in press).
48. Moses, A. V., Fish, K. N., Ruhl, R., Smith, P. P., Strussenberg, J. G., Zhu, L., Chandran, B., and Nelson, J. A. (1999). Long-term infection and transformation of dermal microvas-cular endothelial cells by human herpesvirus 8. J. Virol. 73, 6892-6902.
49. Naranatt, P. P., Krishnan, H. H., Svojanovsky, S. R., Bloomer, C., Mathur, S., and Chandran, B. (2004). Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection. Cancer Res. 64, 72-84.
50. Pfeffer, S., Sewer, A., Lagos-Quintana, M., Sheridan, R., Sander, C., Grässer, F. A., van Dyk, L. F., Ho, C. K., Shu-man, S., Chien, M., Russo, J. J., Ju, J., Randall, G., Lindenbach, B. D., Rice, C. M., Simon, V., Ho, D. D., Zavolan, M., and Tuschl, T. (2005). Identification of microRNAs of the herpesvirus family. Nat. Methods 2, 269-276.
51. Polson, A. G., Wang, D., DeRisi, J., and Ganem, D. (2002). Modulation of host gene expression by the consti-tutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus. Cancer Res. 62,4525-4530.
52. Pyakurel, P., Pak, F., Mwakigonja, A. R., Kaaya, E., Heiden, T., and Biberfeld, P. (2006). Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development. Int. I Cancer 119, 1262-1267.
53. Qian, L. W., Greene, W., Ye, F., and Gao, S. J. (2008). Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin. J. Virol. 82, 11902-11912.
54. Qian, L. W., Xie, J., Ye, F., and Gao, S. J. (2007). Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases. J. Virol. 81,7001-7010.
55. Qin, Z., Dai, L., Slomiany, M. G., Toole, B. P., and Parsons, C. (2010). Direct activation of emmprin and associated pathogenesis by an onco-genic herpesvirus. Cancer Res. 70, 3884-3889.
56. Russell Jones, R., Orchard, G., Zelger, B., and Wilson Jones, E. (1995). Immunostaining for CD31 and CD34 in Kaposi sarcoma. J. Clin. Pathol.48, 1011-1016.
57. Sadagopan, S., Sharma-Walia, N., Veet-til, M. V., Bottero, V., Levine, R., Vart, R. J., and Chandran, B. (2009). Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis. J. Virol. 83, 3342-3364.
58. Sadagopan, S., Sharma-Walia, N., Veet-til, M. V., Raghu, H., Sivakumar, R., Bottero, V., and Chandran, B. (2007). Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression. J. Virol. 81, 3949-3968.
59. Samaniego, F., Markham, P. D., Gen-delman, R., Watanabe, Y., Kao, V., Kowalski, K., Sonnabend, J. A., Pin-tus, A., Gallo, R. C., and Ensoli, B. (1998). Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am. J. Pathol. 152, 1433-1443.
60. Samols, M. A., Hu, J., Skalsky, R. L., and Renne, R. (2005). Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79, 9301-9305.
61. Samols, M. A., Skalsky, R. L., Mal-donado, A. M., Riva, A., Lopez, M. C., Baker, H. V., and Renne, R. (2007). Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog. 3, e65. doi:10.1371/journal.ppat.0030065
62. Schwarz, M., and Murphy, P. M. (2001). Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant.J. Immunol. 167, 505-513.
63. Shan, B., Morris, C. A., Zhuo, Y., Shelby, B. D., Levy, D. R., and Lasky, J. A. (2007). Activation of proMMP-2 and Src by HHV8 vGPCR in human pulmonary arterial endothelial cells. J. Mol. Cell. Cardiol. 42, 517-525.
64. Sharma-Walia, N., Paul, A. G., Bottero, V., Sadagopan, S., Veettil, M. V., Kerur, N., and Chandran, B. (2010). Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion. PLoS Pathog. 6, e1000777. doi:10.1371/journal.ppat.1000777
65. Sharma-Walia, N., Raghu, H., Sadagopan, S., Sivakumar, R., Veettil, M. V., Naranatt, P. P., Smith, M. M., and Chandran, B. (2006). Cyclooxyge-nase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression. J. Virol. 80, 6534-6552.
66. Shin, Y. C., Joo, C. H., Gack, M. U., Lee, H. R., and Jung, J. U. (2008). Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression. Cancer Res. 68, 1751-1759.
67. Sivakumar, R., Sharma-Walia, N., Raghu, H., Veettil, M. V., Sadagopan, S., Bottero, V., Varga, L., Levine, R., and Chandran, B. (2008). Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications.J. Virol. 82,1759-1776.
68. Skobe, M., Brown, L. F., Tognazzi, K., Ganju, R. K., Dezube, B. J., Alitalo, K., and Detmar, M. (1999). Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. Invest. Derma-tol. 113, 1047-1053.
69. Sodhi, A., Montaner, S., Patel, V., Zohar, M., Bais, C., Mesri, E. A., and Gutkind, J. S. (2000). The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res. 60, 4873-4880.
70. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M. F., Clauvel, J. P., Raphael, M., and Degos, L. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276-1280.
71. Staskus, K. A., Zhong, W., Gebhard, K., Herndier, B., Wang, H., Renne, R., Beneke, J., Pudney, J., Anderson, D. J., Ganem, D., and Haase, A. T. (1997). Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells.J. Virol. 71,715-719.
72. Stine, J. T., Wood, C., Hill, M., Epp, A., Raport, C. J., Schweickart, V. L., Endo, Y., Sasaki, T., Simmons, G., Boshoff, C., Clapham, P., Chang, Y., Moore, P., Gray, P. W., and Chantry, D. (2000). KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood 95, 1151-1157.
73. Subramanian, R., Sehgal, I., D'Auvergne, O., and Kousoulas, K. G. (2010). Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells. J. Virol. 84, 1704-1714.
74. Tammela, T., Zarkada, G., Wallgard, E., Murtomäki, A., Suchting, S., Wirze-nius, M., Waltari, M., Hellström, M., Schomber, T., Peltonen, R., Fre-itas, C., Duarte, A., Isoniemi, H., Laakkonen, P., Christofori, G., Ylä-Herttuala, S., Shibuya, M., Pytowski, B., Eichmann, A., Betsholtz, C., and Alitalo, K. (2008). Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454, 656-660.
75. Tomescu, C., Law, W K., and Kedes, D. H. (2003). Surface downreg-ulation of major histocompatibil-ity complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus. Virol. 77, 9669-9684.
76. Vart, R. J., Nikitenko, L. L., Lagos, D., Trotter, M. W., Cannon, M., Bourboulia, D., Gratrix, F., Takeuchi, Y., and Boshoff, C. (2007). Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Cancer Res. 67,4042-4051.
77. Wabinga, H. R., Parkin, D. M., Wabwire-Mangen, F., and Mugerwa, J. W. (1993). Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int. J. Cancer 54, 26-36.
78. Wang, H. W., Trotter, M. W., Lagos, D., Bourboulia, D., Henderson, S., Mäkinen, T., Elliman, S., Flanagan, A. M., Alitalo, K., and Boshoff, C. (2004a). Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat. Genet. 36, 687-693.
79. Wang, L., Wakisaka, N., Tomlinson, C. C., DeWire, S. M., Krall, S., Pagano, J. S., and Damania, B. (2004b). The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res. 64,2774-2781.
80. Wang, L., and Damania, B. (2008). Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res. 68, 4640-4648.
81. Wang, L., Dittmer, D. P., Tomlinson, C. C., Fakhari, F. D., and Damania, B. (2006). Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. Cancer Res. 66, 3658-3666.
82. Weninger, W., Partanen, T. A., Breiteneder-Geleff, S., Mayer, C., Kowalski, H., Mildner, M., Pammer, J., Stürzl, M., Kerjaschki, D., Alitalo, K., and Tschachler, E. (1999). Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab. Invest. 79,243-251.
83. Wigle, J. T., and Oliver, G. (1999). Prox1 function is required for the development of the murine lymphatic system. Cell 98, 769-778.
84. Wu, Y. H., Hu, T. F., Chen, Y. C., Tsai, Y. N., Tsai, Y. H., Cheng, C. C., and Wang, H. W (2011). The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility. Blood 118, 2896-2905.
85. Xie, J., Pan, H., Yoo, S., and Gao, S. J. (2005). Kaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways. J. Virol. 79, 15027-15037.
86. Ye, F. C., Blackbourn, D. J., Mengel, M., Xie, J. P., Qian, L. W., Greene, W., Yeh, I. T., Graham, D., and Gao, S. J. (2007). Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1. J. Virol. 81, 3980-3991.
87. Yoo, J., Kang, J., Lee, H. N., Aguilar, B., Kafka, D., Lee, S., Choi, I., Lee, J., Ramu, S., Haas, J., Koh, C. J., and Hong, Y. K. (2010). Kaposin-B enhances the PROX1 mRNA stability during lymphatic repro-gramming of vascular endothelial cells by Kaposi's sarcoma herpes virus. PLoS Pathog. 6, e1001046. doi:10.1371/journal.ppat.1001046